North America Automated Cell Counting Market Size, Share & Industry Trends Analysis Report By Product, By Application (Cell Line development, Blood Analysis, Stem Cell Research, and Others), By End-use, By Country and Growth Forecast, 2023 - 2030
The North America Automated Cell Counting Market would witness market growth of 11.5% CAGR during the forecast period (2023-2030).
Automated cell counters are statistical instruments utilized in pharmaceutical research, medical diagnostics, and food quality control to quantify and analyze cells. These employ sophisticated methodologies such as flow cytometry and digital imaging to facilitate meticulous and uniform cell examination. The market stands at the forefront of transformative advancements in life sciences, offering a pivotal range of sophisticated instruments and technologies that revolutionize cell analysis.
Automated cell counting represents a critical nexus between technological sophistication and the pursuit of more profound insights into cellular biology. These instruments encompass a diverse array of tools, from flow cytometers to image-based cell counters and automated haematology analysers, each designed to streamline and enhance the analysis of cells across various applications and industries. Defined by cutting-edge innovation, precision, and efficiency, this market caters to the burgeoning demands of scientific research, clinical diagnostics, pharmaceutical developments, and therapeutic innovations.
The increasing incidence of chronic ailments, including diabetes, cancer, and cardiovascular diseases, is a significant catalyst for expanding the market. Continuous monitoring and diagnosis of blood cell counts is necessary for chronic diseases, which increases the use of automated cell counters. According to the Centres for Disease Control and Prevention, the United States' fifth and first primary causes of death, respectively, are heart disease and stroke. Consequently, the increasing prevalence of chronic diseases in the region drives the demand in the market.
The US market dominated the North America Automated Cell Counting Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $2,186.8 million by 2030. The Canada market is experiencing a CAGR of 14% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 13% during (2023 - 2030).
Based on Product, the market is segmented into Consumables & Accessories, and Instruments (Image-based Cell Counters, Flow Cytometers, Electrical Impendence Coulter Counters). Based on Application, the market is segmented into Cell Line development, Blood Analysis, Stem Cell Research, and Others. Based on End-use, the market is segmented into Pharmaceutical & Biotechnology Companies, Hospitals & Diagnostic laboratories, Research & Academic Institutes, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Shanghai Ruiyu Biotechnology Co., Ltd. (Alit Biotech (Shanghai) Co., Ltd.), Thermo Fisher Scientific, Inc., Bio-Rad laboratories, Inc., F. Hoffmann-La Roche Ltd., Danaher Corporation, Olympus Corporation, Merck KGaA, Abbott Laboratories, Sysmex Corporation, and Agilent Technologies, Inc.
Scope of the Study
Market Segments covered in the Report:
By Product
- Consumables & Accessories
- Instruments
- Image-based Cell Counters
- Flow Cytometers
- Electrical Impendence Coulter Counters
- Cell Line development
- Blood Analysis
- Stem Cell Research
- Others
- Pharmaceutical & Biotechnology Companies
- Hospitals & Diagnostic laboratories
- Research & Academic Institutes
- Others
- US
- Canada
- Mexico
- Rest of North America
- Shanghai Ruiyu Biotechnology Co., Ltd. (Alit Biotech (Shanghai) Co., Ltd.)
- Thermo Fisher Scientific, Inc.
- Bio-Rad laboratories, Inc.
- F. Hoffmann-La Roche Ltd.
- Danaher Corporation
- Olympus Corporation
- Merck KGaA
- Abbott Laboratories
- Sysmex Corporation
- Agilent Technologies, Inc.
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
- Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 North America Automated Cell Counting Market, by Product
- 1.4.2 North America Automated Cell Counting Market, by Application
- 1.4.3 North America Automated Cell Counting Market, by End-use
- 1.4.4 North America Automated Cell Counting Market, by Country
- 1.5 Methodology for the research
- Chapter 2. Market at a Glance
- 2.1 Key Highlights
- Chapter 3. Market Overview
- 3.1 Introduction
- 3.1.1 Overview
- 3.1.1.1 Market Composition and Scenario
- 3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- Chapter 4. Competition Analysis - Global
- 4.1 KBV Cardinal Matrix
- 4.2 Recent Industry Wide Strategic Developments
- 4.2.1 Partnerships, Collaborations and Agreements
- 4.2.2 Product Launches and Product Expansions
- 4.2.3 Acquisition and Mergers
- 4.2.4 Trials and Approvals
- 4.3 Top Winning Strategies
- 4.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
- 4.3.2 Key Strategic Move: (Product Launches and Product Expansions: 2019, Jun – 2022, Sep) Leading Players
- 4.4 Porter Five Forces Analysis
- Chapter 5. North America Automated Cell Counting Market by Product
- 5.1 North America Consumables & Accessories Market by Region
- 5.2 North America Instruments Market by Region
- 5.3 North America Automated Cell Counting Market by Instruments Type
- 5.3.1 North America Image-based Cell Counters Market by Country
- 5.3.2 North America Flow Cytometers Market by Country
- 5.3.3 North America Electrical Impendence Coulter Counters Market by Country
- Chapter 6. North America Automated Cell Counting Market by Application
- 6.1 North America Cell Line development Market by Country
- 6.2 North America Blood Analysis Market by Country
- 6.3 North America Stem Cell Research Market by Country
- 6.4 North America Others Market by Country
- Chapter 7. North America Automated Cell Counting Market by End-use
- 7.1 North America Pharmaceutical & Biotechnology Companies Market by Country
- 7.2 North America Hospitals & Diagnostic laboratories Market by Country
- 7.3 North America Research & Academic Institutes Market by Country
- 7.4 North America Others Market by Country
- Chapter 8. North America Automated Cell Counting Market by Country
- 8.1 US Automated Cell Counting Market
- 8.1.1 US Automated Cell Counting Market by Product
- 8.1.1.1 US Automated Cell Counting Market by Instruments Type
- 8.1.2 US Automated Cell Counting Market by Application
- 8.1.3 US Automated Cell Counting Market by End-use
- 8.2 Canada Automated Cell Counting Market
- 8.2.1 Canada Automated Cell Counting Market by Product
- 8.2.1.1 Canada Automated Cell Counting Market by Instruments Type
- 8.2.2 Canada Automated Cell Counting Market by Application
- 8.2.3 Canada Automated Cell Counting Market by End-use
- 8.3 Mexico Automated Cell Counting Market
- 8.3.1 Mexico Automated Cell Counting Market by Product
- 8.3.1.1 Mexico Automated Cell Counting Market by Instruments Type
- 8.3.2 Mexico Automated Cell Counting Market by Application
- 8.3.3 Mexico Automated Cell Counting Market by End-use
- 8.4 Rest of North America Automated Cell Counting Market
- 8.4.1 Rest of North America Automated Cell Counting Market by Product
- 8.4.1.1 Rest of North America Automated Cell Counting Market by Instruments Type
- 8.4.2 Rest of North America Automated Cell Counting Market by Application
- 8.4.3 Rest of North America Automated Cell Counting Market by End-use
- Chapter 9. Company Profiles
- 9.1 Shanghai Ruiyu Biotechnology Co., Ltd. (Alit Biotech (Shanghai) Co., Ltd.)
- 9.1.1 Company Overview
- 9.2 Thermo Fisher Scientific, Inc.
- 9.2.1 Company Overview
- 9.2.2 Financial Analysis
- 9.2.3 Segmental and Regional Analysis
- 9.2.4 Research & Development Expenses
- 9.2.5 Recent strategies and developments:
- 9.2.5.1 Partnerships, Collaborations, and Agreements:
- 9.2.5.2 Product Launches and Product Expansions:
- 9.2.5.3 Acquisition and Mergers:
- 9.2.6 SWOT Analysis
- 9.3 Bio-Rad laboratories, Inc.
- 9.3.1 Company Overview
- 9.3.2 Financial Analysis
- 9.3.3 Segmental and Regional Analysis
- 9.3.4 Research & Development Expenses
- 9.3.5 SWOT Analysis
- 9.4 F. Hoffmann-La Roche Ltd.
- 9.4.1 Company Overview
- 9.4.2 Financial Analysis
- 9.4.3 Segmental and Regional Analysis
- 9.4.4 Research & Development Expense
- 9.4.5 Recent strategies and developments:
- 9.4.5.1 Partnerships, Collaborations, and Agreements:
- 9.4.5.2 Product Launches and Product Expansions:
- 9.4.6 SWOT Analysis
- 9.5 Danaher Corporation
- 9.5.1 Company Overview
- 9.5.2 Financial Analysis
- 9.5.3 Segmental and Regional Analysis
- 9.5.4 Research & Development Expense
- 9.5.5 SWOT Analysis
- 9.6 Olympus Corporation
- 9.6.1 Company Overview
- 9.6.2 Financial Analysis
- 9.6.3 Segmental and Regional Analysis
- 9.6.4 Recent strategies and developments:
- 9.6.4.1 Product Launches and Product Expansions:
- 9.6.5 SWOT Analysis
- 9.7 Merck KGaA
- 9.7.1 Company Overview
- 9.7.2 Financial Analysis
- 9.7.3 Segmental and Regional Analysis
- 9.7.4 Research & Development Expense
- 9.7.5 Recent strategies and developments:
- 9.7.5.1 Product Launches and Product Expansions:
- 9.7.6 SWOT Analysis
- 9.8 Abbott Laboratories
- 9.8.1 Company Overview
- 9.8.2 Financial Analysis
- 9.8.3 Segmental and Regional Analysis
- 9.8.4 Research & Development Expense
- 9.8.5 Recent strategies and developments:
- 9.8.5.1 Trials and Approvals:
- 9.8.6 SWOT Analysis
- 9.9 Sysmex Corporation
- 9.9.1 Company Overview
- 9.9.2 Financial Analysis
- 9.9.3 Regional Analysis
- 9.9.4 Research & Development Expense
- 9.9.5 Recent strategies and developments:
- 9.9.5.1 Partnerships, Collaborations, and Agreements:
- 9.9.5.2 Product Launches and Product Expansions:
- 9.9.6 SWOT Analysis
- 9.10. Agilent Technologies, Inc.
- 9.10.1 Company Overview
- 9.10.2 Financial Analysis
- 9.10.3 Segmental and Regional Analysis
- 9.10.4 Research & Development Expense
- 9.10.5 Recent strategies and developments:
- 9.10.5.1 Product Launches and Product Expansions:
- 9.10.5.2 Acquisition and Mergers:
- 9.10.6 SWOT Analysis
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook